Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedJan 21, 2025
DataAggregated Company Financials
Companies52
  • 7D0.5%
  • 3M-5.2%
  • 1Y0.1%
  • YTD1.2%

Over the last 7 days, the Pharma industry has dropped 1.9%, driven by a pullback from Lumosa Therapeutics of 9.4%. On the other hand Caliway Biopharmaceuticals is actually up 6.3%. Over the last year, the industry has been flat overall. Earnings are forecast to grow by 8.7% annually.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 21 Jan 2025NT$605.6bNT$109.3bNT$11.4b21.1x53x5.5x
Thu, 19 Dec 2024NT$580.8bNT$101.2bNT$11.8b21.5x49.3x5.7x
Sat, 16 Nov 2024NT$620.1bNT$106.3bNT$9.3b24.8x66.5x5.8x
Mon, 14 Oct 2024NT$619.3bNT$104.7bNT$8.9b27.3x69.3x5.9x
Wed, 11 Sep 2024NT$630.3bNT$104.7bNT$8.9b24.4x70.5x6x
Fri, 09 Aug 2024NT$617.5bNT$100.5bNT$6.8b28.1x90.4x6.1x
Sun, 07 Jul 2024NT$708.6bNT$100.5bNT$6.8b32.6x103.8x7x
Tue, 04 Jun 2024NT$627.8bNT$100.4bNT$7.1b29.8x87.8x6.3x
Thu, 02 May 2024NT$627.4bNT$101.8bNT$9.4b25.5x67x6.2x
Sat, 30 Mar 2024NT$646.3bNT$101.2bNT$9.4b26.6x69x6.4x
Mon, 26 Feb 2024NT$641.5bNT$101.6bNT$8.2b23.9x78.7x6.3x
Wed, 24 Jan 2024NT$588.5bNT$101.9bNT$7.8b24x75.5x5.8x
Fri, 22 Dec 2023NT$579.3bNT$101.6bNT$7.6b23.6x76x5.7x
Sun, 19 Nov 2023NT$561.7bNT$101.8bNT$8.4b24.5x66.5x5.5x
Tue, 17 Oct 2023NT$536.6bNT$101.7bNT$9.6b20.9x55.8x5.3x
Thu, 14 Sep 2023NT$551.1bNT$101.7bNT$9.6b22.5x57.3x5.4x
Sat, 12 Aug 2023NT$556.9bNT$98.7bNT$10.1b17.3x55.2x5.6x
Mon, 10 Jul 2023NT$581.6bNT$98.7bNT$10.1b16.9x57.8x5.9x
Wed, 07 Jun 2023NT$585.1bNT$98.4bNT$10.0b16.7x58.5x5.9x
Fri, 05 May 2023NT$586.9bNT$92.1bNT$8.6b23.2x68.4x6.4x
Sun, 02 Apr 2023NT$569.0bNT$91.5bNT$8.7b20.7x65.8x6.2x
Tue, 28 Feb 2023NT$559.2bNT$84.7bNT$7.6b23.6x73.3x6.6x
Thu, 26 Jan 2023NT$484.3bNT$84.6bNT$7.9b20.6x61.4x5.7x
Sat, 24 Dec 2022NT$505.4bNT$84.6bNT$7.9b23.1x64.1x6x
Mon, 21 Nov 2022NT$451.5bNT$84.6bNT$7.7b15.8x58.9x5.3x
Wed, 19 Oct 2022NT$410.3bNT$78.9bNT$4.3b17.3x94.8x5.2x
Fri, 16 Sep 2022NT$462.1bNT$78.9bNT$4.3b18.5x106.8x5.9x
Sun, 14 Aug 2022NT$394.8bNT$77.3bNT$4.9b20.5x81.2x5.1x
Tue, 12 Jul 2022NT$384.5bNT$76.8bNT$4.4b21.9x88x5x
Thu, 09 Jun 2022NT$378.5bNT$76.8bNT$4.4b20.6x86.6x4.9x
Sat, 07 May 2022NT$387.6bNT$76.6bNT$6.5b21.1x59.2x5.1x
Mon, 04 Apr 2022NT$406.3bNT$76.4bNT$6.8b20.6x59.8x5.3x
Wed, 02 Mar 2022NT$408.2bNT$76.5bNT$8.7b19.9x46.9x5.3x
Fri, 28 Jan 2022NT$378.7bNT$76.7bNT$8.5b18.9x44.7x4.9x
Price to Earnings Ratio

44.7x


Total Market Cap: NT$378.7bTotal Earnings: NT$8.5bTotal Revenue: NT$76.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 70.7x202320242025
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 52.5x which is lower than its 3-year average PE of 70.7x.
  • The industry is trading close to its 3-year average PS ratio of 5.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 11% per year over the last three years.
  • Revenues for these companies have grown 13% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market3.46%
Healthcare0.0098%
Pharma0.46%
Pharma0.46%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$703.0012.3%
+NT$11.8b
237.2%PS2158.3x
6932 Mercury BiopharmaceuticalNT$15.7038.3%
+NT$1.8b
-11.5%PS1150.4x
6472 Bora PharmaceuticalsNT$818.001.5%
+NT$1.2b
22.8%PE21.7x
6620 Handa PharmaceuticalsNT$78.2011.2%
+NT$1.1b
-55.3%PE24.4x
1789 ScinoPharm TaiwanNT$22.351.6%
+NT$276.8m
-12.4%PE44.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6472

NT$818.00

Bora Pharmaceuticals

7D

1.5%

1Y

22.8%

6932

NT$15.70

Mercury Biopharmaceutical

7D

38.3%

1Y

-11.5%

6919

NT$703.00

Caliway Biopharmaceuticals

7D

12.3%

1Y

237.2%

4130

NT$24.15

Genovate Biotechnology

7D

5.2%

1Y

-2.8%

6535

NT$234.50

Lumosa Therapeutics

7D

-10.3%

1Y

104.8%

6467

NT$53.00

Taho Pharmaceuticals

7D

5.6%

1Y

n/a

6576

NT$77.10

Foresee Pharmaceuticals

7D

1.0%

1Y

-18.8%

6620

NT$78.20

Handa Pharmaceuticals

7D

11.2%

1Y

-55.3%

1789

NT$22.35

ScinoPharm Taiwan

7D

1.6%

1Y

-12.4%

4114

NT$33.05

Synmosa Biopharma

7D

-2.2%

1Y

-3.1%

6785

NT$126.00

Alar Pharmaceuticals

7D

-6.7%

1Y

-47.5%

4123

NT$40.30

Center Laboratories

7D

-5.2%

1Y

-15.2%

4166

NT$36.35

Orient Pharma

7D

-8.1%

1Y

71.9%

7754

NT$32.55

AnnJi Pharmaceutical

7D

-3.6%

1Y

n/a

1271

NT$69.70

SunWay Biotech

7D

-5.3%

1Y

-41.9%